Correlation study of PBK/TOPK expression, prognosis, and immune infiltration in breast cancer

Abstract PDZ-binding kinase/T-lymphokine-activated killer-cell-originated protein kinase (PBK/TOPK) is a serine-threonine protein kinase. This study aimed to investigate the expression pattern, prognostic significance, and relationship with tumor immune infiltration of PBK/TOPK in breast cancer thro...

Full description

Saved in:
Bibliographic Details
Main Authors: Bingxin Li, Tianze Yao, Min Zhang, Jiaxuan Yu, Jiping Xie, Yi Wan, Yuchuan Ge, Guangze Sun, Yongqiang Yao
Format: Article
Language:English
Published: Nature Portfolio 2025-04-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-96542-1
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850042512169762816
author Bingxin Li
Tianze Yao
Min Zhang
Jiaxuan Yu
Jiping Xie
Yi Wan
Yuchuan Ge
Guangze Sun
Yongqiang Yao
author_facet Bingxin Li
Tianze Yao
Min Zhang
Jiaxuan Yu
Jiping Xie
Yi Wan
Yuchuan Ge
Guangze Sun
Yongqiang Yao
author_sort Bingxin Li
collection DOAJ
description Abstract PDZ-binding kinase/T-lymphokine-activated killer-cell-originated protein kinase (PBK/TOPK) is a serine-threonine protein kinase. This study aimed to investigate the expression pattern, prognostic significance, and relationship with tumor immune infiltration of PBK/TOPK in breast cancer through bioinformatics analyses and immunohistochemistry (IHC), providing insights for individualized treatment and immunotherapy strategies. PBK/TOPK expression and its correlation with clinicopathological features were analyzed using TIMER, UALCAN, and TCGA databases. Prognostic value was assessed via Kaplan–Meier plotter and bc-GenExMiner. Variants of the PBK/TOPK gene and their prognostic implications were explored using cBioPortal. Enrichment analysis in R identified signaling pathways linked to PBK/TOPK. The relationships between PBK/TOPK, tumor-infiltrating lymphocytes (TILs), and immune cell markers were evaluated using TIMER and TISIDB. IHC experiments validated PBK/TOPK expression in tumor samples and its association with prognosis. Meanwhile, IHC also further confirmed the correlation between PBK/TOPK and CD4+ and CD8+ T cells infiltration, as well as the relationship between T cells and breast cancer prognosis. PBK/TOPK was significantly overexpressed in breast cancer tissues compared to normal tissues and correlated with clinicopathological features, including tumor size and lymph node stage. High expression of PBK/TOPK was associated with poor prognosis. While breast cancer subtypes exhibited different PBK/TOPK gene variants, these variants did not influence prognosis. PBK/TOPK is involved in cell meiosis, cytoskeletal motility, and pathways such as FoxO and p53. It is associated with immune infiltration and is differentially expressed in breast cancer subtypes and correlates with TILs and immune cell markers. IHC confirms that PBK/TOPK expression positively correlates with CD4+ T and CD8+ T cells infiltration. CD4+ T cells were positively associated with the prognosis of triple-negative breast cancer. PBK/TOPK is overexpressed in breast cancer tissues, and high expression levels are associated with poor patient prognosis. Additionally, PBK/TOPK is linked to immune infiltration in breast cancer, positively correlating with CD4+ and CD8+ T cells infiltration, suggesting a new avenue for immunotherapy research in breast cancer.
format Article
id doaj-art-cfa49d67d6694f3b99ba1feb1c965ae7
institution DOAJ
issn 2045-2322
language English
publishDate 2025-04-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-cfa49d67d6694f3b99ba1feb1c965ae72025-08-20T02:55:31ZengNature PortfolioScientific Reports2045-23222025-04-0115111910.1038/s41598-025-96542-1Correlation study of PBK/TOPK expression, prognosis, and immune infiltration in breast cancerBingxin Li0Tianze Yao1Min Zhang2Jiaxuan Yu3Jiping Xie4Yi Wan5Yuchuan Ge6Guangze Sun7Yongqiang Yao8Department of Breastplate Surgery, Affiliated Zhongshan Hospital of Dalian UniversityJinzhou Medical UniversityDepartment of Breastplate Surgery, Affiliated Zhongshan Hospital of Dalian UniversityDepartment of Breastplate Surgery, Affiliated Zhongshan Hospital of Dalian UniversityDepartment of Breastplate Surgery, Affiliated Zhongshan Hospital of Dalian UniversityDepartment of Breastplate Surgery, Affiliated Zhongshan Hospital of Dalian UniversityDepartment of Breastplate Surgery, Affiliated Zhongshan Hospital of Dalian UniversityDepartment of Breastplate Surgery, Affiliated Zhongshan Hospital of Dalian UniversityDepartment of Breastplate Surgery, Affiliated Zhongshan Hospital of Dalian UniversityAbstract PDZ-binding kinase/T-lymphokine-activated killer-cell-originated protein kinase (PBK/TOPK) is a serine-threonine protein kinase. This study aimed to investigate the expression pattern, prognostic significance, and relationship with tumor immune infiltration of PBK/TOPK in breast cancer through bioinformatics analyses and immunohistochemistry (IHC), providing insights for individualized treatment and immunotherapy strategies. PBK/TOPK expression and its correlation with clinicopathological features were analyzed using TIMER, UALCAN, and TCGA databases. Prognostic value was assessed via Kaplan–Meier plotter and bc-GenExMiner. Variants of the PBK/TOPK gene and their prognostic implications were explored using cBioPortal. Enrichment analysis in R identified signaling pathways linked to PBK/TOPK. The relationships between PBK/TOPK, tumor-infiltrating lymphocytes (TILs), and immune cell markers were evaluated using TIMER and TISIDB. IHC experiments validated PBK/TOPK expression in tumor samples and its association with prognosis. Meanwhile, IHC also further confirmed the correlation between PBK/TOPK and CD4+ and CD8+ T cells infiltration, as well as the relationship between T cells and breast cancer prognosis. PBK/TOPK was significantly overexpressed in breast cancer tissues compared to normal tissues and correlated with clinicopathological features, including tumor size and lymph node stage. High expression of PBK/TOPK was associated with poor prognosis. While breast cancer subtypes exhibited different PBK/TOPK gene variants, these variants did not influence prognosis. PBK/TOPK is involved in cell meiosis, cytoskeletal motility, and pathways such as FoxO and p53. It is associated with immune infiltration and is differentially expressed in breast cancer subtypes and correlates with TILs and immune cell markers. IHC confirms that PBK/TOPK expression positively correlates with CD4+ T and CD8+ T cells infiltration. CD4+ T cells were positively associated with the prognosis of triple-negative breast cancer. PBK/TOPK is overexpressed in breast cancer tissues, and high expression levels are associated with poor patient prognosis. Additionally, PBK/TOPK is linked to immune infiltration in breast cancer, positively correlating with CD4+ and CD8+ T cells infiltration, suggesting a new avenue for immunotherapy research in breast cancer.https://doi.org/10.1038/s41598-025-96542-1PBK/TOPKBreast cancerExpressionPrognosisImmune infiltration
spellingShingle Bingxin Li
Tianze Yao
Min Zhang
Jiaxuan Yu
Jiping Xie
Yi Wan
Yuchuan Ge
Guangze Sun
Yongqiang Yao
Correlation study of PBK/TOPK expression, prognosis, and immune infiltration in breast cancer
Scientific Reports
PBK/TOPK
Breast cancer
Expression
Prognosis
Immune infiltration
title Correlation study of PBK/TOPK expression, prognosis, and immune infiltration in breast cancer
title_full Correlation study of PBK/TOPK expression, prognosis, and immune infiltration in breast cancer
title_fullStr Correlation study of PBK/TOPK expression, prognosis, and immune infiltration in breast cancer
title_full_unstemmed Correlation study of PBK/TOPK expression, prognosis, and immune infiltration in breast cancer
title_short Correlation study of PBK/TOPK expression, prognosis, and immune infiltration in breast cancer
title_sort correlation study of pbk topk expression prognosis and immune infiltration in breast cancer
topic PBK/TOPK
Breast cancer
Expression
Prognosis
Immune infiltration
url https://doi.org/10.1038/s41598-025-96542-1
work_keys_str_mv AT bingxinli correlationstudyofpbktopkexpressionprognosisandimmuneinfiltrationinbreastcancer
AT tianzeyao correlationstudyofpbktopkexpressionprognosisandimmuneinfiltrationinbreastcancer
AT minzhang correlationstudyofpbktopkexpressionprognosisandimmuneinfiltrationinbreastcancer
AT jiaxuanyu correlationstudyofpbktopkexpressionprognosisandimmuneinfiltrationinbreastcancer
AT jipingxie correlationstudyofpbktopkexpressionprognosisandimmuneinfiltrationinbreastcancer
AT yiwan correlationstudyofpbktopkexpressionprognosisandimmuneinfiltrationinbreastcancer
AT yuchuange correlationstudyofpbktopkexpressionprognosisandimmuneinfiltrationinbreastcancer
AT guangzesun correlationstudyofpbktopkexpressionprognosisandimmuneinfiltrationinbreastcancer
AT yongqiangyao correlationstudyofpbktopkexpressionprognosisandimmuneinfiltrationinbreastcancer